Related by context. All words. (Click for frequent words.) 58 clinical 51 EmbraceAC 51 clevidipine 51 TBC# 51 Instanyl 51 phase IIa clinical 50 galiximab 50 OvaRex 50 MabThera rituximab 50 EGS# 50 pharmacological therapies 50 BETAS 50 phase IIIb 49 clinical pharmacology studies 49 double blinded randomized 49 microplasmin Phase III 49 riociguat 49 Ketotransdel 49 thorough QT 49 Valdoxan 49 phase IIb III 49 BNC# 49 orally inhaled migraine 48 tipranavir 48 Phase IIIB IV 48 haematological cancers 48 Cloretazine ® 48 TLK# 48 dextofisopam 48 lumiliximab 48 dexanabinol 48 midstage clinical 48 BrachySil TM 48 ProSavin 48 Phase 1a clinical 48 Zemplar Capsules 48 antiangiogenic agents 48 EDEMA3 trial 48 Clinical 48 clincal 48 Phase Ib clinical 48 M6G 48 oral ridaforolimus 48 DXL# 48 CHAMPION PCI 48 phase IIb 47 Phase IIIb clinical 47 phase IIb clinical 47 radiographic outcomes 47 Ereska 47 Zybrestat 47 everolimus eluting stents 47 diabetic neuropathic pain 47 ELACYT 47 CA9 SCAN 47 Azedra TM 47 oral methylnaltrexone 47 fostamatinib 47 blinded randomized controlled 47 Phase IIIb study 47 almorexant 47 tecarfarin 47 efficacy tolerability 47 randomized Phase IIb 47 BRAF inhibitor 47 pertuzumab 47 indicates cardio circulatory 47 preclinical efficacy 47 RE LY ® 47 Vascular Wrap TM 47 phase IIa 47 pharmacokinetic PK study 47 placebo controlled clinical 47 Phase #b/#a 47 viral kinetics 47 CaPre TM 47 TKM ApoB 47 including eniluracil ADH 47 R#/MEM 47 CLARITY study 47 ORENCIA R 47 Elocalcitol 47 pharmacodynamic properties 47 CRLX# 47 ChronVac C R 47 eculizumab therapy 46 GSK# [002] 46 DAPT 46 Phase 2b clinical trials 46 ASCEND HF 46 NP2 Enkephalin 46 MGN# 46 PREOS R 46 placebo controlled Phase III 46 aesthetic dermatological conditions 46 XL# SAR# 46 Glybera R 46 CARE HF 46 Pyridorin 46 GLPG# 46 oxymorphone ER 46 RSD# oral 46 intravenous methylnaltrexone 46 ONCONASE R 46 PREGNANT Study 46 Phase Ib IIa clinical 46 Androxal TM 46 immunotherapeutic vaccine 46 tasimelteon 46 antithrombotic therapy 46 Phase #b/#a trial 46 briakinumab 46 budesonide MMX Phase III 46 cannabinor 46 Huntexil 46 rALLy 46 Rezular 46 elotuzumab 46 AeroLEF TM 46 pharmaco 46 Cloretazine R VNP#M 46 eosinophilic asthma 46 BRIM3 46 IL# PE#QQR 46 lomitapide 46 cardiometabolic 46 trastuzumab DM1 46 clazosentan 46 CINQUIL 46 BioSante LibiGel Phase III 46 safinamide 46 clinical trial 46 convenient dosing regimen 46 pharmacologic treatments 46 AQUAVAN R 46 MYDICAR 46 PRIMO CABG 46 ABSORB trial 46 OncoVEX GM CSF 46 Proellex TM 46 RE LY 46 CAPHOSOL 46 balsalazide tablet 45 postapproval 45 prospective multicenter 45 Cloretazine 45 TOCOSOL Paclitaxel 45 farletuzumab 45 Prodarsan ® 45 midstage trials 45 metaanalysis 45 clinicial 45 angiographic outcomes 45 fosbretabulin 45 Vascular Wrap 45 randomized blinded 45 fidaxomicin Phase 3 45 elacytarabine 45 oral PTH 45 isavuconazole 45 Actilon 45 Q#IR 45 teriflunomide 45 bicifadine 45 Archexin 45 liprotamase 45 GAMMAGARD 45 PREOS 45 AERx iDMS 45 davunetide intranasal AL 45 PD2i ® 45 pivotal bioequivalence 45 BLA filing 45 metastatic sarcomas 45 elagolix 45 Itopride 45 pain palliation 45 Hedgehog inhibitor 45 recombinant PSMA vaccine 45 PK PD modeling 45 Ceflatonin 45 subcutaneous immunoglobulin 45 MAXY alpha 45 investigational therapies 45 Phase IIb III 45 GGF2 45 Phase III randomized controlled 45 Cancidas 45 cystinosis patients 45 visilizumab 45 vernakalant hydrochloride 45 palifosfamide 45 Aryplase 45 tezampanel NGX# 45 LibiGel ® Phase III 45 Azedra 45 Voraxaze ™ 45 rHuPH# 45 MEND CABG II 45 pharmacokinetic pharmacodynamic 45 velafermin 45 opioid induced bowel dysfunction 45 Nonclinical 45 treating neuropathic pain 45 confirmatory Phase III 45 nonclinical studies 45 oncologic 45 gefitinib Iressa 45 Prodarsan R 45 Phase III VISTA 44 ADAGIO study 44 KRN# 44 Ophena TM 44 Phase IIB 44 HGS# 44 bardoxolone methyl 44 pharmacotherapies 44 Altrazeal TM Silver 44 sunitinib malate 44 Adlea TM 44 GLP toxicology studies 44 SUTENT ® 44 lenalidomide Revlimid R 44 candidates Dyloject TM 44 preclinically 44 Aplidin 44 recurrent herpes labialis 44 hematological malignancy 44 metabolite identification 44 immatics 44 pharmacoeconomic 44 systemic RNAi 44 therapeutic regimens 44 Phase IIa trials 44 ticagrelor Brilinta 44 Dacogen injection 44 OLYMPIA registry 44 MYCAMINE 44 Urocortin 2 44 Zoraxel 44 Desmoteplase 44 Phase III TRIST 44 PRT# 44 Posidur 44 SNT MC# 44 Panzem R NCD 44 schizophrenia CIAS 44 alvespimycin 44 incyclinide 44 intranasal formulation 44 Meta analyzes 44 Edwards SAPIEN valve 44 Phase Ib study 44 PDE4 inhibitor 44 dacetuzumab 44 bosutinib 44 tonabersat 44 mecarbil 44 INTERCEPT platelets 44 AVADO 44 GLP toxicology 44 alemtuzumab MS 44 Fentanyl TAIFUN R 44 Pharma Medica 44 cangrelor 44 lintuzumab 44 OHR/AVR# 44 ancrod 44 zileuton CR 44 punctal plug drug 44 Zevalin consolidation 44 oral RSD# 44 Tarek Sherif CEO 44 neratinib 44 IIa trials 44 INCB# [001] 44 invasive candidiasis 44 OnDose TM 44 preclinical pharmacokinetic 44 phase Ib 44 canakinumab 44 SILENOR 44 Phase Ib II 44 postoperative ileus POI 44 CCX# 44 Virulizin ® 44 micafungin 44 IMA# 44 OvaRex R 44 Phase #/#a 44 Rasagiline 44 enzastaurin 44 RhuDex ® 44 alvimopan 44 OPTTX 44 clinical trials 44 MAXY VII 44 GRN# 44 Hyphanox 44 phase IIb study 44 Combo Stent 44 CYT# potent vascular disrupting 44 CBLC# 43 phase IIb trial 43 pharmacodynamic PD 43 renal anemia 43 vidofludimus 43 tolevamer 43 Alequel 43 Allovectin 7 43 aerosolized KL4 surfactant 43 PHX# 43 R#/MEM # 43 Evoltra ® 43 PANVAC VF 43 phase III ACCLAIM 43 reslizumab 43 ReN# 43 Val HeFT 43 ruxolitinib 43 clinicaltrials 43 EOquin TM 43 MAGE A3 ASCI 43 TQT studies 43 ACTILON 43 sulodexide 43 MyVax personalized immunotherapy 43 IIa clinical trials 43 rALLy trial 43 Zenvia ™ 43 guideline concordant 43 dermaPACE TM 43 Solazed 43 temsirolimus Torisel ® 43 Phase 1b trial 43 Alocrest 43 forodesine 43 oncology virology 43 Phase IIb clinical trials 43 Phase 2b clinical 43 ospemifene 43 VTE prevention 43 acute ischemic stroke 43 ENMD # 43 bioequivalency 43 MERLIN TIMI 43 UPLYSO 43 Mipomersen 43 MGd 43 QOPI 43 Corlux 43 International Nasdaq PRAI 43 intranasal insulin 43 Nivestim 43 Mepact 43 AERx 43 ALGRX 43 Cloretazine R 43 RhuDex 43 Cogane 43 SEPET TM 43 Oral NKTR 43 vemurafenib 43 NEXTERONE 43 vivo pharmacology 43 QTinno TM 43 clinically 43 Numoda 43 BST CarGel R 43 confirmatory clinical 43 Phase 1b clinical 43 Ophena 43 SinuNase TM 43 BR.# 43 Sulonex 43 RE COVER 43 OvaRex ® MAb 43 novel oral anticoagulant 43 EOquin 43 RESOLUTE clinical 43 Neurostep TM 43 renin inhibition 43 CytoFab ™ 43 trastuzumab DM1 T DM1 43 TriGrid 43 ALN PCS 42 CINTREDEKIN BESUDOTOX 42 Zingo TM 42 CIPN 42 Quinamed 42 Proxinium TM 42 therapeutic armamentarium 42 therapeutic monoclonal antibody 42 stage hypoxia activated 42 senicapoc 42 perfusion CT 42 CLORETAZINE TM VNP#M 42 Nasulin 42 prospective nonrandomized 42 oral taxane 42 vinca alkaloid 42 PMA submission 42 intravenous acetaminophen 42 CoFactor 42 luliconazole 42 oral talactoferrin 42 torezolid phosphate 42 LibiGel ® 42 Novolimus 42 Lauren Silvernail 42 analgesic efficacy 42 Triapine R 42 PDE# inhibitors 42 REG1 42 oral prodrug 42 revision hip arthroplasty 42 refractory angina 42 TRIST study 42 pharmacogenetic 42 JAK2 inhibitors 42 rEEG 42 IMC #B 42 Oasmia 42 AQ4N 42 Bicifadine 42 candidate TNFerade biologic 42 punctal plug delivery 42 Annamycin 42 HuMax EGFr 42 Capesaris 42 human microdosing 42 www.nextrials.com 42 Phase IIIb 42 Clonicel 42 FavId 42 Nanobody ® 42 ColorectAlert TM 42 multicenter Phase II 42 LibiGel Phase III 42 zanolimumab 42 eTag assays 42 Rhucin R 42 Ketotransdel TM 42 teduglutide 42 plaque excision 42 Trofex 42 sacral nerve stimulation 42 pharmacotherapeutic 42 Entereg R 42 AZILECT ® 42 preclinical toxicology 42 vosaroxin 42 HCV polymerase inhibitor 42 herpetic keratitis 42 prelicensure 42 OraTest R 42 omecamtiv mecarbil 42 microRNA profiling 42 BEXXAR 42 viral kinetic 42 IRX 2 42 ADVANCE PD 42 pharmacokinetic PK 42 GCP compliant 42 AA Amyloidosis 42 PFO migraine 42 Adlea 42 deforolimus 42 anti angiogenic agents 42 OMAPRO 42 postoperative ileus 42 Dr Gillian Braunold 42 novel therapeutic antibodies 42 NeuroFlo 42 BioLife enabling 42 entinostat 42 preclinical pharmacology 42 Myocet 42 gepirone ER 42 thetreatment 42 EXPAREL 42 Factor VIIa 42 prospective multicenter study 42 p# inhibitor 42 eprotirome 41 HQK 41 PEARL SC 41 selective androgen receptor modulator 41 BEMA TM Fentanyl 41 Hedgehog agonist 41 EGEN 41 adipiplon 41 PORxin TM platforms 41 ESBA# 41 prospective longitudinal 41 Phase 2a clinical trials 41 Stedivaze 41 catheter occlusion 41 subcutaneous formulation 41 HCD# [002] 41 VITAL Trial 41 YONDELIS 41 StemEx R 41 eTag assay 41 Bioaccelerate compounds under 41 vivo preclinical 41 Phase IIb trials 41 Phase IIa trial 41 haematologic 41 obatoclax 41 THALOMID 41 targeted radiotherapeutic 41 relapsed multiple myeloma 41 Phase Ia 41 diagnostic prognostic 41 Fx #A 41 HeFH 41 injectable formulations 41 ularitide 41 tezampanel 41 SUCCEED trial 41 acute decompensated heart 41 tolerability profiles 41 biomarker identification 41 POSIDUR TM 41 pharmacogenetic testing 41 Phase 2a clinical 41 INFUSE ® 41 cerebral oximetry 41 Prednisporin TM 41 methylnaltrexone 41 Renal Cell Carcinoma RCC 41 INOmax R 41 Perforomist ™ Inhalation Solution 41 predictive biomarkers 41 NTx ® -# 41 EndoTAG TM 41 OvaRex MAb 41 blood clot dissolver 41 bioabsorbable stent 41 tubulin inhibitor 41 IIa clinical 41 molecular imaging radiopharmaceutical 41 QLT# 41 biostatistical 41 Acute Decompensated Heart Failure 41 OncoVEX 41 Icatibant 41 UltiMAb R technology 41 PLK1 SNALP 41 IND enabling 41 celgosivir 41 tremelimumab 41 HORIZONS AMI trial 41 INS# [001] 41 budesonide foam 41 bardoxolone 41 IV acetaminophen 41 Panzem R 41 MOZOBIL 41 Mpex 41 faropenem 41 multicenter trials 41 Fibrocaps 41 ACRIN 41 Exherin TM 41 FFR measurements 41 Phase IIb clinical 41 eniluracil 41 aripiprazole Abilify 41 RelayHealth securely processes 41 Squalamine 41 Prostate Px + 41 genomic biomarker 41 REMINYL ® 41 TRO# 41 TELINTRA 41 IIa trial 41 AMPAKINE CX# 41 ALTROPANE 41 Acute Coronary Syndromes ACS 41 lexidronam injection 41 interventional cardiac 41 evaluating Nexavar 41 Gag polymorphisms 41 Phase Ib 40 inhalation toxicology 40 Vicinium TM 40 IMPROVE HF 40 CB2 selective receptor agonist 40 Rheos System 40 Zemiva TM 40 GEM OS2 40 interventional neuroradiology 40 psychometrically sound 40 XmAb 40 PSN# [002] 40 Removab 40 Plenaxis TM 40 renal 40 EP #R 40 ganaxolone 40 omacetaxine 40 ASONEP 40 clinical pharmacology 40 Surfaxin LS 40 favorable pharmacokinetic profile 40 PD2i Analyzer 40 Intraject 40 rt PA 40 preclinical 40 torcetrapib atorvastatin 40 Vasogen Celacade TM 40 COR Analyzer 40 Nanobodies ® 40 MyVax ® 40 CB1 antagonists 40 constipation OIC 40 personalized immunotherapy 40 rxRNA 40 Simulect 40 Phase 2b study 40 maribavir 40 investigational HCV polymerase 40 inVentiv Clinical 40 biliary tract cancer 40 Vion Pharmaceuticals 40 Lixivaptan 40 pharmacokinetic 40 RELOVAIR ™ 40 MEND CABG 40 fibrin sealant 40 bioanalysis 40 CytoFabTM 40 Inc. Nasdaq NLTX 40 rALLy clinical trial 40 therapeutic 40 Exelixis compounds 40 candidate CRLX# 40 PK PD 40 interventional therapies 40 unblinding 40 Hedgehog antagonist 40 postmarket safety 40 ADME 40 pharmacoeconomics 40 OXi# 40 Zenvia Phase III 40 psychopharmacological 40 Viprinex 40 IND submission 40 Neovasc Reducer 40 HORIZONS AMI 40 SPARLON 40 Sernova Cell Pouch 40 clinically validated 40 CRMD# 40 TKM PLK1 40 clinically meaningful 40 Cleviprex TM clevidipine 40 Personalized Oncology 40 Cellegesic 39 Puricase PEG uricase 39 PRECISE trial 39 Soliris TM eculizumab 39 epigenetic therapies 39 Vilazodone 39 kidney urologic 39 non alcoholic steatohepatitis 39 Kendle NASDAQ KNDL 39 B. Lynne Parshall 39 BioMAP 39 molecular oncology 39 ostarine 39 oxypurinol 39 Fabry Disease 39 Sudhir Agrawal D.Phil 39 peri operative 39 PICSO ® 39 EDEMA3 39 TRV# [001] 39 EECP ® 39 Cardio Vascu Grow 39 data management Clintrial 39 ATIR TM 39 Genasense ® 39 CIP ISOTRETINOIN 39 multicenter clinical trials 39 abstracts summarizing 39 Phase IIa 39 PEG PAL 39 Aurora kinase inhibitors 39 rindopepimut 39 Aerosurf 39 dirucotide MBP# 39 anidulafungin 39 Ceflatonin R 39 GI endoscopy 39 rhC1INH 39 PORxin TM 39 ENDEAVOR IV 39 ALN TTR# 39 GeneSightRx 39 null responder 39 ataluren 39 Liprotamase 39 Wellstat 39 REVEAL Registry 39 procedural sedation 39 opioid analgesia 39 Stimuvax R 39 Phase IIb trial 39 Neuradiab 39 TMS Therapy 39 hematologic oncology 39 EECP R 39 oral antiviral 39 coronary intervention 39 CardioFit 39 pharmacogenetic tests 39 Glenveigh 39 rFactor XIII 39 EC Cysteamine 39 FVIIa 39 Neo Kidney Augment ™ 39 sodium thiosulfate STS 39 COMFORT II 39 Phase IIb 39 Intarcia 39 rBChE 39 Clinical Trial 39 Cx# [002] 39 Referenced EEG ® 39 Zavesca r 39 Phase IIa clinical 39 Nanobody 39 JAK inhibitor 39 bioanalytical laboratories 39 NSABP 39 non nucleoside 39 cartilage regeneration 38 Phase III clinical 38 ProTrials Research 38 Electronic Brachytherapy 38 Accelovance 38 opioid induced constipation 38 AcelRx 38 cGMP manufacture 38 Durata 38 COU AA 38 XP #L 38 JAK2 inhibitor 38 FFR measurement 38 CCR9 antagonist 38 Xcytrin R 38 CR# vcMMAE 38 QTinno 38 noninfectious uveitis 38 postmarketing surveillance 38 randomized trials 38 Neuradiab TM 38 Amigal 38 Phase III trials 38 Tolerx 38 Kendle Nasdaq KNDL 38 atherosclerosis regression 38 urology oncology 38 daptomycin 38 cancer immunotherapies 38 ganetespib 38 biomarker 38 isoform selective 38 Metricath Gemini 38 daclizumab 38 hematology microbiology 38 predictive toxicology 38 pharmacokinetic studies 38 recurrent glioma 38 FOLOTYN ® 38 optimal dosing regimens 38 molecular profiling 38 solid organ transplantation 38 rheumatologic 38 REALITY Trial 38 Proxinium 38 severe hypercholesterolemia 38 clinically relevant 38 GEM OS1 38 AzaSite Plus 38 NEUMUNE 38 AFRS TM 38 LEUKINE 38 Referenced EEG 38 pharmacoepidemiology 38 KL4 surfactant 38 dirucotide 38 tafamidis 38 Onalta 38 cardiotoxic effects 38 efficacy 38 registrational 38 EECP ® therapy 38 XmAb ® 38 NovaBay Aganocide compounds 38 Lymphoseek ® 38 SJTRI 38 Altrazeal ® 38 radezolid 38 GI motility disorders 38 Phase 2a trial 38 Medifacts 38 recombinant factor VIIa 38 biomarker discovery 37 lorvotuzumab mertansine 37 Memryte 37 leading oral taxane 37 NATRECOR ® 37 Hepatocellular Carcinoma HCC 37 SYNTAX trial 37 PROSTVAC TM 37 ALN HTT 37 pharmacologic 37 Sigma Tau SpA 37 biased ligand 37 crofelemer 37 DermTech International 37 BioDisc 37 YONDELIS R 37 oncology 37 Syndax Pharmaceuticals Inc. 37 radiolabeled TM# 37 PsychoGenics 37 kinase profiling 37 Dalbavancin 37 randomized clinical trials 37 huN# DM1 37 Phase 2b trial 37 BACcel 37 invivodata 37 adipose derived stem cell 37 Sulonex TM 37 RIGScan CR 37 KuDOS 37 Fibrin Pad 37 Preclinical 37 Celacade TM 37 Neo Kidney Augment 37 Phase III clinical trials 37 LymphoStat B 37 pharmacogenomic testing 37 immunological diseases 37 Aethlon Hemopurifier R 37 Pervasis 37 Aurexis 37 Tragara Pharmaceuticals Inc. 37 Plicera 37 Tovaxin ® 37 DFCI 37 personalized cellular immunotherapy 37 Celator 37 Sequenom CMM 37 clinical informatics 37 cardio renal 36 DDP# 36 pediatric 36 Avastin adjuvant 36 Prednisporin 36 anticoagulation 36 RGB # 36 TACI Ig 36 oncology dermatology 36 prostone 36 Cethromycin 36 mechanical thrombectomy 36 Dataflow Manager 36 Sunrise Ambulatory Care 36 GED aPC 36 EchoCRT 36 Cutanea 36 pivotal Phase III 36 DPX Survivac 36 OZURDEX ® 36 VEGF Trap 36 retrospective observational study 36 Tectin TM 36 ViaCyte 36 external counterpulsation systems 36 pharmacodynamic 36 Aganocide 36 HERmark assay 36 NTDDS platform 36 eRT 36 CURE AF 36 talactoferrin 36 AZX# 36 oncology neurology 36 neurology cardiology 36 cytopathology 36 translational medicine 35 ICA # 35 translational research 35 pediatric bipolar disorder 35 Altastaph 35 oncology cardiology 35 tiapamil 35 postmarket surveillance 35 Cortex AMPAKINE 35 AssureRx 35 Cethrin 35 ePRO 35 pediatric rheumatology 35 Periowave TM Photodisinfection System 35 tolerability 35 diagnostic 35 psychiatry neurology 35 UltiMAb ® 35 pharmacology 35 pharmacogenetics 35 CellerateRx 35 ToleroMune 35 gynecologic procedures 35 Toraymyxin TM 35 tumor immunology 35 endocrinology oncology 35 Chrysalin 35 companion diagnostics 35 HGS ETR1 35 ZEVALIN ® 35 preclinical studies 35 patient 35 perioperative 35 ZFP Therapeutic 35 topically applied SEPA 35 INxin TM 35 AVN# [001] 34 Serdaxin 34 Phase 1b 34 NEUGENE antisense 34 interprofessional education 34 Dynogen 34 NTDDS 34 patients 34 Clinical Research 34 TNFerade TM 34 Firazyr ® 34 pharmacovigilance 34 ophthalmology dermatology cardiovascular disease 34 HEOR 34 gastroenterological 34 Targeted Chemotherapy 34 nicotinic alpha 7 34 Catabasis 34 Med eMonitor System 34 vilazodone 34 HealthCore 34 Jean Pierre Sommadossi Ph.D. 34 Facet Solutions 33 Hemopurifier 33 Medidata Rave 33 biologic 33 prehospital 33 Zavesca R 33 HIV integrase inhibitors 33 resuscitative measures 33 therapeutics 33 perinatal 33 nonclinical 33 neuroimmunology 33 HspE7 33 Manja Bouman CEO 33 Opexa 32 clinician 32 cardiothoracic surgical 32 clinicians 32 Xanodyne 32 TYZEKA 32 Veronate 32 therapeutic antibody 32 Clinical Trials 32 immunology 32 ophthalmology 32 molecular pathology 31 interventional pulmonology 31 REMOXY ® 31 transplantation immunology 31 AspenBio 31 CDRD 30 Aethlon Hemopurifier ® 30 biologics 30 pharmacogenomics 29 KineMed 29 investigational 29 gastroenterology 28 neurosurgical 28 OFIRMEV 28 pediatric intensivists 27 ACORN CRO 27 dermatologic 20 physicians